BVS Q2 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$137M-2.3% YoY

Gross Profit

$89M65.0% margin

Operating Income

$7M4.9% margin

Net Income

-$4M-2.7% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+15.1%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$9M

Stock-Based Comp.

-$3M

Balance Sheet

Total Assets

$837M

Total Liabilities

$604M

Stockholders' Equity

$183M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$137M	$140M	-2.3%
Gross Profit	$89M	$97M	-7.8%
Operating Income	$7M	-$3M	+304.1%
Net Income	-$4M	-$7M	+49.2%

Geographic Segments

UNITED STATES

$33M86%

Non-US

$5M14%